Abstract
Prostatic cancer is the second most frequent cause of cancer death in males in most countries of the Western world, causing 9 to 10% of all cancer deaths every year. This death rate is exceeded only by lung cancer, and is followed by deaths from gastrointestinal tumors. Incidence and death from prostatic carcinoma are strongly age dependent, 75% of all prostatic carcinomas being diagnosed between the ages of 55 and 75 years.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Cantrell BB, DeKIerk DP, Eggleston JC, Boitnott JK, Walsh PC: Pathological factors that influence prognosis in stage A prostatic cancer: the influence of extent versus grade. J Urol 1981 (125):516–520
Akazaki K, Stemmermann GN: Comparative study of latent carcinoma of the prostate among Japanese in Japan and Hawai. JNCI 1973 (50,5):1137–1144
Breslow N, Chan CW, Dhom G, Drury RAB, Franks LM, Gellei B, Lee YS, Lundsberg S, Sparke B, Sternby NH, Tulinius H: Latent carcinoma of prostate at autopsy in seven areas. Int J Cancer 1977 (20):680–688
Zaridze DG, Boyle P, Smans M: International trends in prostatic cancer. Int J Cancer 1984 (33):223–230
Wynder EL, Mabuchi K, Whitmore WF: Epidemiology of cancer of the prostate. Cancer 1971 (28):344–360
Flanders WD: Review: prostate cancer epidemiology. The Prostate 1984 (5):621–629
McNeal JE: Origin and evolution of prostatic carcinoma. In: Ablin RJ (ed) Prostatic Cancer. Marcel Dekker Inc, New York/Basle 1981 pp 43–50
Whitmore WF: The natural history of prostatic cancer. Cancer 1973 (32): 1104
Mettlin C, Natarajan N, Murphy GP: Recent patterns of care of prostate cancer patients in the United States: results from the surveys of the American College of Surgeons Commission on Cancer. Int Adv Surg Oncol 1982 (5):277–321
Byar DP, Corle DK, Veterans Administration Cooperative Urological Research Group: VACURG randomized trial of radical prostatectomy for stage I and II prostate cancer. Urology 1981 (Suppl 12,4):7–11
Kramer SA, Cline WA, Farnham R, Carson CC, Cox EB, Hinshaw W, Paulson DF: Prognosis of patients with stage D1 prostatic carcinoma. J Urol 1981 (125):817
McCullough DL: Diagnosis and staging of prostatic cancer. In: Skinner DG, deKernion JB (eds) Genito-Urinary Cancer. Saunders, Philadelpha 1978 p 295
Catalona WJ, Scott WW: Carcinoma of the prostate. In: Harrison JH, Gittes RF, Perlmutter AD, Stamey TA, Walsh PC (eds) Campbell’s Urology. Saunders, Philadelphia 1979 p 1085
Byar D: VACURG studies on prostatic cancer and its treatment. In: Tannenbaum Lea M and Febger (eds) Urologie Pathology: The Prostate. New York 1977 pp 241–267
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Schröder, F.H. (1988). Aspects of Epidemiology, Pathogenesis and Natural History of Prostatic Cancer. In: Denis, L. (eds) The Medical Management of Prostate Cancer. ESO Monographs. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73238-6_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-73238-6_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-73240-9
Online ISBN: 978-3-642-73238-6
eBook Packages: Springer Book Archive